<- Go Home
InterCure Ltd.
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Market Cap
ILS 235.3M
Volume
147.9K
Cash and Equivalents
ILS 78.3M
EBITDA
-ILS 78.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
ILS 42.1M
Profit Margin
17.61%
52 Week High
ILS 8.59
52 Week Low
ILS 4.54
Dividend
N/A
Price / Book Value
0.59
Price / Earnings
-3.37
Price / Tangible Book Value
1.37
Enterprise Value
ILS 368.7M
Enterprise Value / EBITDA
-5.09
Operating Income
-ILS 87.9M
Return on Equity
17.03%
Return on Assets
-7.09
Cash and Short Term Investments
ILS 78.7M
Debt
ILS 211.4M
Equity
ILS 397.7M
Revenue
ILS 238.8M
Unlevered FCF
-ILS 18.3M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium